Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Björn Borre
Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study
BMC Neurology
Medicine
Neurology
Related publications
Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy
Multiple Sclerosis
Neurology
Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study
BMC Neurology
Medicine
Neurology
Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis
PLoS ONE
Multidisciplinary
Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study
Journal of the Neurological Sciences
Neurology
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings From the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental